Marimed (MRMD) Change in Accured Expenses (2011 - 2026)

Marimed (MRMD) has 16 years of Change in Accured Expenses data on file, last reported at $829000.0 in Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at $829000.0, down 56.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.1 million (down 17.56% YoY), and the FY2025 annual result was $3.2 million, up 80.27% from the prior year.
• Change in Accured Expenses rose to $829000.0 in Q1 2026 per MRMD's latest filing, from $259000.0 in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $1.9 million in Q1 2025 and troughed at -$1.7 million in Q4 2023.
• A 5-year average of $201352.9 and a median of -$136000.0 in 2024 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses slumped 491.0% in 2023, then jumped 627.05% in 2024.
• A 5-year view of Change in Accured Expenses shows it stood at -$289000.0 in 2022, then tumbled by 491.0% to -$1.7 million in 2023, then jumped by 39.58% to -$1.0 million in 2024, then jumped by 125.1% to $259000.0 in 2025, then surged by 220.08% to $829000.0 in 2026.
• Business Quant data shows MRMD's Change in Accured Expenses at $829000.0 in Q1 2026, $259000.0 in Q4 2025, and $1.3 million in Q3 2025.